Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global High-content Screening (HCS) Market Forecast to 2024 -

Research and Markets
Posted on: 13 Dec 18

The "High-content Screening Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to's offering.

The report predicts the global high-content screening market to grow with a CAGR of 10.1% over the forecast period of 2018-2024.

The study on high-content screening market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.

The report on high-content screening market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global high-content screening market over the period of 2016 to 2024.

Report Findings


  • Latest Development in the High-Content Screening (HCS) Technology and Its Significance in Drug Discovery
  • Introduction of Several New Products by the Market Players


  • High Price of High Contents Screening Instruments


  • Growing Government Funding Helps to Research and Development for Drug Discovery

Company Profiles

  • Merck Millipore
  • Bio-Rad Laboratories Inc.
  • Tecan Trading AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Perkinelmer Inc.
  • BioTek Instruments Inc.
  • GE Healthcare
  • Cell Signalling Technologies Inc.

Key Topics Covered

1. Preface

2. Executive Summary

3. Global High-Content Screening Market Overview

4. High-Content Screening Market Macro Indicator Analysis

5. Global High-Content Screening Market by Application

6. Global High-Content Screening Market by End User

7. Global High-Content Screening Market by Product

8. Global High-Content Screening Market by Region

9. Company Profiles and Competitive Landscape

For more information about this report visit

View source version on

Business Wire

Last updated on: 13/12/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.